1 김지원, "한국인에서 조현병과 Cannabinoid Receptor 1 유전자의 삼핵산 반복서열의 연합에 대한 연구" 대한생물정신의학회 21 (21): 99-106, 2014
2 이창희, "한국인에서 정신분열병환자의 안구추적운동 이상과 Dystrobrevin Binding Protein 1 (DTNBP1) 유전자의 SNP A(T>A)와 P1763(A>C) 다형성의 연합에 대한 연구" 대한생물정신의학회 13 (13): 275-284, 2006
3 장호준, "한국인 정신분열병 환자의 안구추적운동 이상과 COMT 유전자의 Val108/158Met 다형성의 연합 연구" 대한생물정신의학회 15 (15): 288-296, 2008
4 Almeida B, "Trinucleotide repeats: a structural perspective" 4 : 76-, 2013
5 Gagnon D, "Transcranial magnetic stimulation of frontal oculomotor regions during smooth pursuit" 26 : 458-466, 2006
6 D’Souza DC, "The psychotomimetic effects of intravenous delta-9-tetra hydrocannabinol in healthy individuals: implications for psychosis" 29 : 1558-1572, 2004
7 Skosnik PD, "The effect of chronic cannabinoids on broadband EEG neural oscillations in humans" 37 : 2184-2193, 2012
8 Krauzlis RJ, "The control of voluntary eye movements: new perspectives" 11 : 124-137, 2005
9 Cuthbert BN, "The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology" 13 : 28-35, 2014
10 Matsuda LA, "Structure of a cannabinoid receptor and functional expression of the cloned cDNA" 346 : 561-564, 1990
1 김지원, "한국인에서 조현병과 Cannabinoid Receptor 1 유전자의 삼핵산 반복서열의 연합에 대한 연구" 대한생물정신의학회 21 (21): 99-106, 2014
2 이창희, "한국인에서 정신분열병환자의 안구추적운동 이상과 Dystrobrevin Binding Protein 1 (DTNBP1) 유전자의 SNP A(T>A)와 P1763(A>C) 다형성의 연합에 대한 연구" 대한생물정신의학회 13 (13): 275-284, 2006
3 장호준, "한국인 정신분열병 환자의 안구추적운동 이상과 COMT 유전자의 Val108/158Met 다형성의 연합 연구" 대한생물정신의학회 15 (15): 288-296, 2008
4 Almeida B, "Trinucleotide repeats: a structural perspective" 4 : 76-, 2013
5 Gagnon D, "Transcranial magnetic stimulation of frontal oculomotor regions during smooth pursuit" 26 : 458-466, 2006
6 D’Souza DC, "The psychotomimetic effects of intravenous delta-9-tetra hydrocannabinol in healthy individuals: implications for psychosis" 29 : 1558-1572, 2004
7 Skosnik PD, "The effect of chronic cannabinoids on broadband EEG neural oscillations in humans" 37 : 2184-2193, 2012
8 Krauzlis RJ, "The control of voluntary eye movements: new perspectives" 11 : 124-137, 2005
9 Cuthbert BN, "The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology" 13 : 28-35, 2014
10 Matsuda LA, "Structure of a cannabinoid receptor and functional expression of the cloned cDNA" 346 : 561-564, 1990
11 Edwards CR, "Sensory gating impairments in heavy cannabis users are asso ciated with altered neural oscillations" 123 : 894-904, 2009
12 Zammit S, "Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study" 325 : 1199-, 2002
13 Fakhoury M, "Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia" 15-, 2016
14 La Spada AR, "Repeat expansion disease: progress and puzzles in disease pathogenesis" 11 : 247-258, 2010
15 Doherty JL, "Recent genomic advances in schizophrenia" 81 : 103-109, 2012
16 Wong DF, "Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMAR" 52 : 1505-1513, 2010
17 Johns A, "Psychiatric effects of cannabis" 178 : 116-122, 2001
18 Henquet C, "Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people" 330 : 11-, 2005
19 Nagel M, "Parametric modulation of cortical activation during smooth pursuit with and without target blanking. an fMRI study" 29 : 1319-1325, 2006
20 Lencer R, "Neurophysiology and neuroanatomy of smooth pursuit in humans" 68 : 219-228, 2008
21 Singer W, "Neuronal synchrony: a versatile code for the definition of relations?" 24 : 49-65, 1999
22 Pasaje CF, "Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population" 10 : 828-833, 2011
23 Van Essen DC, "Neural mechanisms of form and motion processing in the primate visual system" 13 : 1-10, 1994
24 Munro S, "Molecular characterization of a peripheral receptor for cannabinoids" 365 : 61-65, 1993
25 Ono S Das VE, "Modeling of smooth pursuit-related neuronal responses in the DLPN and NRTP of the rhesus macaque" 93 : 108-116, 2005
26 McMurray CT, "Mechanisms of trinucleotide repeat instability during human development" 11 : 786-799, 2010
27 Halikas JA, "Marihuana use and psychiatric illness" 27 : 162-165, 1972
28 Annese J, "Localization of the human cortical visual area MT based on computer aided histological analysis" 15 : 1044-1053, 2005
29 Kim JH, "Lack of associations of neuregulin 1 variations with schizophrenia and smooth pursuit eye movement abnormality in a Korean population" 46 : 476-482, 2012
30 Skosnik PD, "It’s All in the Rhythm:The role of cannabinoids in neural oscillations and psychosis" 79 : 568-577, 2016
31 Devane WA, "Isolation and structure of a brain constituent that binds to the cannabinoid receptor" 258 : 1946-1949, 1992
32 Vigano D, "Involvement of the endocannabinoid system in phencyclidineinduced cognitive deficits modelling schizophrenia" 12 : 599-614, 2009
33 Dawson E, "Genetic association between alleles of pancreatic phospholipase A2gene and bipolar affective disorder" 5 : 177-180, 1995
34 Bae JS, "Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population" 24 : 225-229, 2014
35 Pazos MR, "Functional neuroanatomy of the endocannabinoid system" 81 : 239-247, 2005
36 Woo SI, "Eye tracking abnormality in schizophrenic inpatients" 18 : 100-108, 1993
37 Jung CY, "Eye tracking abnormality in schizophrenia:follow up study after 4 months" 34 : 369-377, 1995
38 Rais M, "Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients" 165 : 490-496, 2008
39 Morrison PD, "Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms" 36 : 827-836, 2011
40 Lencer R, "Cortical mechanisms of smooth pursuit eye movements with target blanking. An fMRI study" 19 : 1430-1436, 2004
41 Potvin S, "Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis" 100 : 242-251, 2008
42 Brookes MJ, "Changes in brain network activity during working memory tasks: a magnetoencephalography study" 55 : 1804-1815, 2011
43 Spencer DJ, "Cannabis-induced psychosis" 6 : 323-326, 1971
44 Arseneault L, "Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study" 325 : 1212-1213, 2002
45 van Os J, "Cannabis use and psychosis: a longitudinal population-based study" 156 : 319-327, 2002
46 Andréasson S, "Cannabis and schizophrenia. A longitudinal study of Swedish conscripts" 2 : 1483-1486, 1987
47 Chavarría-Siles I, "Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia" 147 : 279-284, 2008
48 Ujike H, "CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia" 7 : 515-518, 2002
49 Roche M, "Brain CB2 Receptors: Implications for Neuropsychiatric Disorders" 3 : 2517-2553, 2010
50 Tsai SJ, "Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia" 10 : 149-151, 2000
51 Shin HD, "Association of ZDHHC8 polymorphisms with smooth pursuit eye movement abnormality" 153B : 1167-1172, 2010
52 Cheong HS, "Association of RANBP1 haplotype with smooth pursuit eye movement abnormality" 156B : 67-71, 2011
53 Lee YJ, "Association analysis between the G72/G30 single nucleotide polymorphisms (rs947267 and rs77829) and smooth pursuit eye movement (SPEM)abnormality of patients with schizophrenia in Korean population" 13 : 42-49, 2010
54 Braun DI, "Anticipatory smooth eye movements and predictive pursuit after unilateral lesions in human brain" 110 : 111-116, 1996
55 Leweke FM, "Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use" 94 : 29-36, 2007
56 Koethe D, "Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis" 194 : 371-372, 2009
57 Karayiorgou M, "A turning point in schizophrenia genetics" 19 : 967-979, 1997
58 Sugiura T, "2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain" 215 : 89-97, 1995
59 Martínez-Gras I, "(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population" 256 : 437-441, 2006